We are proud to have reached a major milestone! The AMYPAD Diagnostic and Patient Management Study (DPMS) has reached out 50% of the recruitment target, with a total of 450 patients enrolled since the study was initiated last April 2018.  Congratulations to the entire team!

Thanks are also due to our Principal Investigator Giovanni Frisoni (Geneva, UNIGE) who has inspired our multiple AMYPAD sites across Europe to include their memory clinic patients as part of this cohort as well as Christian Moro (Geneva, UNIGE) who has guided all the sites through multiple operational challenges and continues to motivate our investigators and scientists to drive this study to completion. 

Our goal to recruit a total of 900 participants with an initial work-up of either subjective cognitive decline, mild cognitive impairment or suspected AD dementia is now within reach.